US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Julius Baer Group Ltd (1BAER) 銘柄情報

Julius Baer Group Ltd (1BAER)

0.00

0.00

(0.00%)

終了 6月15日 12:30AM

Julius Baer Group Ltd (1BAER) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

54.50 52 週間の範囲 76.50

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

560,222 €

発行済株式数

204,995,768

配当利回り

2.6 (4.06%)

PER

17.69

1 株当たり利益 (EPS)

3.71

歳入

3.76B

純利益

763.7M

Julius Bär Gruppe AG provides wealth management solutions in Switzerland, Europe, the Americas, Asia, and internationally. The company provides investment advisory and discretionary mandates; structured products, securities execution and advisory, and private markets and fund offering; wealth planni... Julius Bär Gruppe AG provides wealth management solutions in Switzerland, Europe, the Americas, Asia, and internationally. The company provides investment advisory and discretionary mandates; structured products, securities execution and advisory, and private markets and fund offering; wealth planning, and family office services. It also offers open product platform services. Julius Bär Gruppe AG was founded in 1890 and is headquartered in Zurich, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.juliusbaer.com

本社

Zurich, Switzerland

設立

1890

Julius Baer Group Ltd is listed in the sector of the イタリア証券取引所 with ticker 1BAER. The last closing price for Julius Baer was -. Over the last year, Julius Baer shares have traded in a share price range of 54.50 € to 76.50 €.

Julius Baer currently has 204,995,768 shares in issue. Julius Baer has a price to earnings ratio (PE ratio) of 17.69.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	69.62	71.38	69.62	163	71.03714286	DE
4	0	0	73.2	74.58	67.44	298	70.82345265	DE
12	0	0	61.5	74.58	61.5	161	71.0393633	DE
26	0	0	63.5	76.5	61.5	86	70.93217889	DE
52	0	0	56	76.5	54.5	60	68.0199918	DE
156	0	0	56.5	76.5	54.5	56	68.0199918	DE
260	0	0	56.5	76.5	54.5	56	68.0199918	DE

1BAER - Frequently Asked Questions (FAQ)

What is the current Julius Baer Group Ltd share price?

The current share price of Julius Baer Group Ltd is 0.00 €

How many Julius Baer Group Ltd shares are in issue?

Julius Baer Group Ltd has 204,995,768 shares in issue

What is the 1 year trading range for Julius Baer Group Ltd share price?

Julius Baer Group Ltd has traded in the range of 54.50 € to 76.50 € during the past year

What is the PE ratio of Julius Baer Group Ltd?

The price to earnings ratio of Julius Baer Group Ltd is 17.69

What is the cash to sales ratio of Julius Baer Group Ltd?

The cash to sales ratio of Julius Baer Group Ltd is 3.58

What is the registered address of Julius Baer Group Ltd?

The registered address for Julius Baer Group Ltd is Bahnhofstrasse 36, Zurich, Zurich, 8010

What is the Julius Baer Group Ltd website address?

The website address for Julius Baer Group Ltd is www.juliusbaer.com

GetSeriousOK

GetSeriousOK 7分前

Seriously, you're pretending that the patents aren't expired? You know better.

And why do you care? Nobody else cares whether BIEL's devices are patented or not. Mayer doesn't care, so why do you?

If somebody other than Mayer wanted to get generic devices from CICD Shen

Investor082

Investor082 8分前

Yup, a bunch of BS artists. But it tells you LP has nothing meaningful up her sleeve and endless dilution in pennies is going to continue for months and years. Easy money for LP’s financiers to play both ways and anyone that wants to bet against false promises and expectations they set moving forwar

Eli's Gone

Eli's Gone 9分前

I'm in: 11-19-5-43

Eli's Gone

Eli's Gone 9分前

theorysuit

theorysuit 9分前

FDA already told them no and would have rejected them on the spot with no chance of appeal as the uK allows. They are hiding out appealing the UK rejection almost 3 years later. LP said they won't update on the UK submission ....lmfao at this POS

surfkast

surfkast 10分前

Sadly the OTC King was basically a king in his own mind. Three of his companies are dark. His Canadian scammer buddy Luis Sapi is promoting the VitaCaeli Emergency Use Resuscitator through dark FORW which is also defunct EM! Good luck getting the current anytime soon. The claim is a US patent ha

theorysuit

theorysuit 12分前

It's obvious they cant submit the FDA but you are bursting the pipedreams of the FDA for the pump crew. This company has nothing

Investor082

Investor082 12分前

LOL, only LP to blame, but she loves excuses and playing a victim card! ;)

US Market News

US Market News 12分前

AV Introduces TOM 50 RE, a Backpackable UGV for Rapid Reconnaissance and Explosive Ordnance DisposalJune 14, 2026 11:45 AM
Business Wire Lightweight uncrewed ground vehicle expands mission flexibility for highly mobile units operating in complex and contested e

Vexari

Vexari 12分前

theorysuit

theorysuit 13分前

It's funny. The few things LP does say and the pumpers accuse you of her or Lg never saying things like multiple submissions or direct restart or they are on the last mile 10 years ago. Nwbo pays people to refute what they said ....lmfao pathetic.

HyGro

No Rx Co. views UK as an attractive market. Industry and trade-policy analyses frame the U.S. as the primary profit engine for global pharma, with European markets like the UK viewed more as volume and reference-pricing anchors than drivers of economic rent.
Large manufacturers have explicit

cableguy

cableguy 14分前

So what??? NO BUDDY CARES HERE IN THE SWAMP CELLAR they all go up when the news is good, you guys do this all the time, really what you are doing is SELF BLOVIATION & SELF GRATIFCATION why do you feel the need to do this, that's a mental health issue, IHUB aught to offer Psychiatrist to help. thats

Investor082

Investor082 15分前

Liar! But enjoy the endless dilution in pennies! ;)

tredenwater2

tredenwater2 17分前

Dr Missling is advertising for a new position at a small biotech through these postings imo. This may be a good sign to come once the current CEO settles the final severance payout.

3331

BIEL #1 on the Breakout Board and #1 Most Read Board the past 24 hours! Better than the SpaceX IPO!
https://i.postimg.cc/prCCScR0/BCO-4fc70e99-1e43-4669-9c94-51c39deb7670.png

learningcurve2020

learningcurve2020 19分前

She also knew MHRA approval requires a web of various groups chiming in, and is going through massive flux do to politics and financial constraints. 🤷‍♀️

BBANBOB

BBANBOB 21分前

Tepper alone supposedly has about 86 bill coming back to HIM ALONE if even the smaller of the BIG $ guesses are wrong and I can assure you he would fight for that........

NOW there has been speculation by many that SOME SORT OF SIDE deal was made with DA BOYZ not sure how that could b

Flip it

Flip it 21分前

https://www.tipranks.com/news/heres-why-top-b-riley-analyst-raised-marvell-mrvl-stock-price-target-by-more-than-40

Sunnybank

Sunnybank 21分前

Thought he had a perfect game going. Sucks either way. Schlittler hung tough and got the win. Went deep enought to lower his ERA. Our AllStar game starters perhaps.

Sunnybank

Sunnybank 21分前

Thought he had a perfect game going. Sucks either way. Schlittler hung tough and got the win. Went deep enought to lower his ERA. Our AllStar game starters perhaps.

3331

BIEL #1 on the Breakout Board and #1 Most Read Board the past 24 hours! Better than the SpaceX IPO!
https://i.postimg.cc/prCCScR0/BCO-4fc70e99-1e43-4669-9c94-51c39deb7670.png

learningcurve2020

learningcurve2020 22分前

Your thinking is what’s warped. It’s called HAVING A TRACK RECORD OF SUCCESS. Musk has all the right stuff including solid patents. Next he’ll invent a cryo facility to store humans until a cure is found. Btw, what do you think SpaceX’s value would be if their facility was owned by the Chinese?

surfkast

surfkast 23分前

Nothing can be done until there is a reading of the will which I am betting there is one. So stop the nonsense. Plus this is a known worthless shell due to the SEC and too many other issues.
Try posting facts. Thanks.

HyGro

FDA cost more (est. $1.2 million) but the value of the approval is so much more valuable because U.S. approval opens the most profitable market in the world. Approval in the UK is likely going to be unprofitable for NWBO as pricing is so low due to NICE.

Host Hotels and Resorts

Eckert & Ziegler

Casual Male Retail

Deciphera Pharmaceuticals

Euronext G Societe Gener...

Virtus Seix Senior Loan ...

Ansar Financial and Deve...

1.625% until 04/32 1.625...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。